NR4A1 and breast carcinoma: The second hypothesis concerned identifying which patients with hormone receptor-positive early breast cancer have a sufficiently good prognosis such that standard of care medical treatment, often comprising adjuvant endocrine therapy alone, was sufficient and which group should be considered for additional therapies.